Viewing Study NCT07418203


Ignite Creation Date: 2026-03-26 @ 3:16 PM
Ignite Modification Date: 2026-03-30 @ 12:31 AM
Study NCT ID: NCT07418203
Status: COMPLETED
Last Update Posted: 2026-02-18
First Post: 2026-02-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Knowledge of 18-19 Years Old About Papillomavirus and HPV Vaccination
Sponsor: Université de Reims Champagne-Ardenne
Organization:

Study Overview

Official Title: Knowledge of 18-19 Years Old About Papillomavirus and HPV Vaccination
Status: COMPLETED
Status Verified Date: 2026-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CO-HPV
Brief Summary: Today, cancers associated with papillomavirus infection affect 6,300 new people each year in France, men and women combined. The papillomavirus vaccine is currently the only vaccine that protects against HPV-associated cancers. However, in its report on vaccination coverage for 2024, Santé Publique France reveals that 41.5% and 37.4% of the 18- and 19-year-old French population respectively have a complete vaccination schedule.

Information, education and communication about HPV are essential to enable the entire population to make informed and responsible decisions about HPV.

Increasing information and immunization coverage for papillomavirus is part of the government's ambitious health plans with the national sexual health strategy and college vaccination campaign.
Detailed Description: The main objective is to describe knowledge of girls and boys aged 18-19 about papillomavirus and HPV vaccination

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: